MSD International GmbH/MSD Ireland (Carlow), Ireland (manufacturing, primary packaging and analytical testing, stability testing)

The drug is used for the prevention of cytomegalovirus (CMV) infection reactivation and CMV disease in adult patients who have received an allogeneic hematopoietic stem cell transplant or a kidney transplant from a CMV-seropositive donor.

Dosage form: concentrate for infusion solution

ATC: J05AX18